St. Jude Creates New Neuroscience Department, Hires NIH Veteran Bönnemann — St. Jude Children's Research Hospital, Inc.

Event summary

St. Jude Children’s Research Hospital created a new Department of Genomic and Translational Neuroscience on March 12, 2026.
Carsten Bönnemann, MD, former NIH clinician-scientist, appointed as department chair.
Bönnemann specializes in pediatric neuromuscular and neurogenetic disorders.
New department aims to advance genetic precision therapies for catastrophic neurological disorders.
Department houses two centers: CPNDR for basic research and CENT for clinical development.

The big picture

St. Jude's creation of a dedicated neuroscience department underscores the growing focus on genetic precision therapies for rare pediatric neurological disorders. The hire of Carsten Bönnemann, a leader in neuromuscular research, signals an aggressive push into an underserved area of pediatric healthcare. The integration of laboratory discovery, therapy development, and clinical delivery under one roof positions St. Jude as a potential leader in this niche but critical segment of medical research.

What we're watching

Research Output: The pace at which the new department will produce actionable discoveries in pediatric neurological disorders.
Therapeutic Development: Whether St. Jude can translate its genomic research into effective clinical treatments for rare neurological conditions.
Industry Collaboration: How Bönnemann's NIH connections will influence cross-institutional partnerships and funding opportunities.